LARGE B-CELL LYMPHOMA (LBCL)
Clinical trials for LARGE B-CELL LYMPHOMA (LBCL) explained in plain language.
Never miss a new study
Get alerted when new LARGE B-CELL LYMPHOMA (LBCL) trials appear
Sign up with your email to follow new studies for LARGE B-CELL LYMPHOMA (LBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR-T therapy aims to beat High-Risk lymphoma in early treatment
Disease control Recruiting nowThis study tests a treatment called CD19 CAR-T therapy for people newly diagnosed with a fast-growing type of large B-cell lymphoma that is hard to treat. About 40 adults will receive the therapy to see if it can make the cancer disappear completely. The goal is to improve outcom…
Matched conditions: LARGE B-CELL LYMPHOMA (LBCL)
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New hope for Hard-to-Treat lymphoma: experimental drug surovatamig enters phase 2 trial
Disease control Recruiting nowThis study tests an experimental drug called surovatamig (AZD0486) in adults with B-cell non-Hodgkin lymphoma that has come back or stopped responding to at least two prior treatments. The goal is to see how well the drug shrinks tumors and to check for side effects. About 240 pa…
Matched conditions: LARGE B-CELL LYMPHOMA (LBCL)
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC